Recent News

• 11.20.2025 - ClearPoint Neuro Completes Acquisition of IRRAS
• 11.06.2025 - ClearPoint Neuro Reports Third Quarter 2025 Results
• 11.06.2025 - ClearPoint Neuro Announces Agreement to Acquire IRRAS
• 11.05.2025 - ClearPoint Neuro to Participate in Multiple Global Healthcare Conferences in the Fourth Quarter of 2025
• 10.07.2025 - ClearPoint Neuro Announces Promising Results from Brain Tumor Laser Therapy Study to be Presented at the CNS Annual Meeting in Los Angeles
• 10.06.2025 - ClearPoint Neuro Announces Expanded International Clearances for Key Therapy Delivery Product; Now Totaling 34 Countries Worldwide
• 10.01.2025 - ClearPoint Neuro Announces Development and Demonstration of the Company's Proprietary Robotic Neuro-Navigation System

Recent Filings

• 11.12.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 11.12.2025 - 144 Report of proposed sale of securities
• 11.06.2025 - 8-K Current report
• 11.06.2025 - EX-99.1 EX-99.1
• 11.06.2025 - 8-K Current report
• 11.06.2025 - EX-99.1 EX-99.1
• 11.06.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 10.14.2025 - 4 Statement of changes in beneficial ownership of securities
• 10.14.2025 - 4 Statement of changes in beneficial ownership of securities
• 10.10.2025 - 144 Report of proposed sale of securities